Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation – Technavio

NEW YORK, Feb. 2, 2024 /PRNewswire/ — The Heart Transplantation Therapeutics Market is set for substantial growth, projecting a notable increase of USD 135.37 million at a stable CAGR of 3.24% between 2023 and 2028, according to Technavio’s latest forecast. The global heart transplantation therapeutics market has a variety of drugs available in different dosage forms, which contributes to its growth. This includes extended-release tablets, delayed-release capsules, dispersible granules, and powder for injection. These factors positively impact the market’s trajectory. For a more comprehensive understanding of the market trends and opportunities, request a Free Sample Report.

What are the Growth Drivers, Trends, and Challenges?

Growth Drivers: The heart transplantation therapeutics market’s growth is notably influenced by the dependency on immunosuppressants, especially for heart transplantation.Trends: A significant trend shaping the market is the advent of techniques for heart transplantation. Researchers are using regenerative therapies to revolutionize heart transplants.Challenges: The market faces challenges due to adverse effects associated with immunosuppressants. These drugs reduce organ rejection but have side effects impacting patient adherence.

What are the key insights? Market Segmentation: and Regional Impact
Market Segmentation: This report meticulously segments the market based on Drug Class, Distribution Channel, and Geography. The immunosuppressants segment is projected to witness substantial growth, holding the largest market share due to their effectiveness in preventing organ rejection.
Regional Overview: North America is projected to contribute 35% to the global market’s growth during the forecast period. The region’s market growth is fueled by increased sales of immunosuppressants.View Free Sample Report.

Who’s Navigating the Competitive Landscape?
Some of the key players in the heart transplantation therapeutics market, including AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., and others, strategically navigate market dynamics. For a comprehensive understanding, purchase the full report.

Related Reports:
The Global Addiction Therapeutics Market size is estimated to grow at a CAGR of 7.65% between 2022 and 2027. The addiction therapeutics market size is forecast to increase by USD 9.86 billion.
The Gonorrhea Therapeutics Market size is estimated to grow by USD 506.68 million at a CAGR of 5.47% between 2022 and 2027.

Table Of Contents :

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Deployment

7 Market Segmentation by Type

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Competitive Landscape

12 Companies Analysis

13 Appendix

About US

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/heart-transplantation-therapeutics-market-projected-for-usd-135-37-million-growth-between-2024-and-2028-market-to-focus-on-newer-techniques-for-heart-transplantation—technavio-302049500.html

SOURCE Technavio